Current liabilities increased 33.0%
Current liabilities changed +33.0% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
$1.4B→$1.9B4 prior comparisons
GROSSPATTERN / DETERMINISTIC EVIDENCE / V3
Search securities →ELAN financial changes
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Working capital decreased 12.5%
Working capital changed -12.5% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
$2.2B→$1.9B4 prior comparisons
Current ratio decreased 21.0%
Current ratio changed -21.0% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
2.6→2.054 prior comparisons
Free-cash-flow proxy increased 35.6%
Free-cash-flow proxy changed +35.6% from the comparable as-filed period.
$180.0M→$244.0M3 prior comparisons
Operating cash flow increased 16.9%
Operating cash flow changed +16.9% from the comparable as-filed period.
$237.0M→$277.0M3 prior comparisons
Capex / revenue moved 218 bp lower
Capex / revenue changed -218 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
4.59%→2.41%2 prior comparisons
Shares outstanding increased 0.6%
Shares outstanding changed +0.6% from the comparable as-filed period. The change ranks at the 88th percentile of 8 prior comparable changes.
496,813,702→499,621,8308 prior comparisons
Inventory / revenue moved 526 bp lower
Inventory / revenue changed -526 basis points from the comparable as-filed period.
134.57%→129.31%2 prior comparisons
Working capital / assets moved 183 bp lower
Working capital / assets changed -183 basis points from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
16.17%→14.34%4 prior comparisons
Revenue increased 10.2%
Revenue changed +10.2% from the comparable as-filed period.
$1.2B→$1.4B2 prior comparisons
Capital expenditure decreased 42.1%
Capital expenditure changed -42.1% from the comparable as-filed period.
$57.0M→$33.0M3 prior comparisons
Trade receivables increased 8.9%
Trade receivables changed +8.9% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
$989.0M→$1.1B4 prior comparisons
Debt / revenue moved 5085 bp lower
Debt / revenue changed -5085 basis points from the comparable as-filed period.
318.61%→267.76%2 prior comparisons
Gross margin moved 88 bp higher
Gross margin changed +88 basis points from the comparable as-filed period.
57.45%→58.33%2 prior comparisons
Free-cash-flow margin moved 333 bp higher
Free-cash-flow margin changed +333 basis points from the comparable as-filed period.
14.50%→17.84%2 prior comparisons
Net debt decreased 8.3%
Net debt changed -8.3% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
$3.4B→$3.1B4 prior comparisons
Gross debt decreased 7.4%
Gross debt changed -7.4% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
$4.0B→$3.7B4 prior comparisons
Reported total debt decreased 7.4%
Reported total debt changed -7.4% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
$4.0B→$3.7B4 prior comparisons
Current long-term debt increased 19.7%
Current long-term debt changed +19.7% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
$61.0M→$73.0M4 prior comparisons
Debt / assets moved 176 bp lower
Debt / assets changed -176 basis points from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
28.77%→27.01%4 prior comparisons
Current assets increased 5.1%
Current assets changed +5.1% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
$3.6B→$3.8B4 prior comparisons
Selling, general & administrative increased 12.2%
Selling, general & administrative changed +12.2% from the comparable as-filed period.
$400.0M→$449.0M2 prior comparisons
Total assets decreased 1.3%
Total assets changed -1.3% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes. This reverses 2 consecutive comparable moves in the opposite direction.
$13.7B→$13.6B4 prior comparisons
Inventory increased 5.9%
Inventory changed +5.9% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
$1.7B→$1.8B4 prior comparisons
Gross profit increased 11.9%
Gross profit changed +11.9% from the comparable as-filed period.
$713.0M→$798.0M0 prior comparisons
Cost of revenue increased 8.0%
Cost of revenue changed +8.0% from the comparable as-filed period.
$528.0M→$570.0M2 prior comparisons
SBC / revenue moved 15 bp lower
SBC / revenue changed -15 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
1.61%→1.46%2 prior comparisons
R&D / revenue moved 69 bp lower
R&D / revenue changed -69 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
7.41%→6.73%2 prior comparisons
Cash / debt moved 84 bp higher
Cash / debt changed +84 basis points from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
13.63%→14.47%4 prior comparisons
Operating cash-flow margin moved 115 bp higher
Operating cash-flow margin changed +115 basis points from the comparable as-filed period.
19.10%→20.25%2 prior comparisons
Receivables / revenue moved 97 bp lower
Receivables / revenue changed -97 basis points from the comparable as-filed period.
79.69%→78.73%2 prior comparisons
Cash & equivalents decreased 1.7%
Cash & equivalents changed -1.7% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
$539.0M→$530.0M4 prior comparisons
Research & development unchangedd 0.0%
Research & development changed +0.0% from the comparable as-filed period.
$92.0M→$92.0M2 prior comparisons
Stock-based compensation unchangedd 0.0%
Stock-based compensation changed +0.0% from the comparable as-filed period.
$20.0M→$20.0M3 prior comparisons
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.